Australia's largest stock trading and investment forum Australia's #1 stock forum

ACTINOGEN MEDICAL LIMITED

8.70%

2.5¢

Market Cap $76.25M

Healthcare Biotechnology

Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel... Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel therapy for neurological diseases associated with dysregulated brain cortisol. There is a strong association between cortisol and detrimental changes in the brain, affecting cognitive function, harm to brain cells and long term cognitive health.More

Corporate Spotlight

Actinogen is a neurotherapeutics developer realizing a revolutionary therapy so neurology patients and their families can live their best lives.
View the full Corporate Spotlight

Actinogen reaches 100th participant milestone

Latest Threads

Tag

Subject

Ann: ACW CEO Q&A at Bioshares 2025

08:00

10

2.8K

08:00

Last post NZ Trader

10

2.8K

Ann: Notification of buy-back - ACW

07/08/25

6

2.6K

07/08/25

Last post revolution

6

2.6K

Ann: Actinogen June 2025 quarterly activity report & Appendix 4C

30/07/25

1

808

30/07/25

Last post butcherano

1

808

Ann: ACW presents key clinical data at AAIC dementia meeting

28/07/25

2

1.2K

28/07/25

Last post stormer

2

1.2K

2025 will be the year

3 4 5

25/07/25

282

114K

25/07/25

Last post stormer

282

114K

ACW , exciting 6 months ahead !

23/07/25

9

3.6K

23/07/25

Last post stormer

9

3.6K

Ann: ACW 100th AD trial participant & interim analysis timeline

18/07/25

23

11K

18/07/25

Last post jellyroll

23

11K

Ann: ACW accesses up to $13.8m in non-dilutive R&D tax funding

02/07/25

12

4.1K

02/07/25

Last post Lait

12

4.1K

With 100 enrolled and $13.8M in hand, Actinogen's Xanamem timeline is in full swing

30/06/25

1

698

30/06/25

Last post Jakjazz

1

698

Misspelly

25/06/25

1

864

25/06/25

Last post Misspelly

1

864

Ann: ACW presents at BIO international partnering conference

22/06/25

32

10K

22/06/25

Last post jellyroll

32

10K

Calm and Objective

13/06/25

53

18K

13/06/25

Last post stormer

53

18K

Estimating Actinogen's potential value - per Grok

13:22

3

1.6K

13:22

Last post stormer

3

1.6K

Ann: ACW Science Forum today - Preparing for commercialization

2

26/05/25

74

26K

26/05/25

Last post Stealth101

74

26K

Ann: Ceasing to be a substantial holder

21/05/25

0

686

21/05/25

Last post

ASX News

0

686

Ann: Actinogen CMO presents positive depression data at APA 2025

20/05/25

5

2.3K

20/05/25

Last post stormer

5

2.3K

See All Discussions

Corporate Spotlight

ABOUT US

Timeline

ACW CEO Q&A at Bioshares 2025
07 Aug 08:27	Share

Actinogen June 2025 quarterly activity report & Appendix 4C
30 Jul 08:55	Share

Notification of buy-back - ACW
30 Jul 08:31	Share

ACW presents key clinical data at AAIC dementia meeting
28 Jul 09:46	Share

ACW accesses up to $13.8m in non-dilutive R&D tax funding
30 Jun 09:11	Share

ACW 100th AD trial participant & interim analysis timeline
30 Jun 08:57	Share

ACW presents at BIO international partnering conference
16 Jun 09:00	Share

Ceasing to be a substantial holder
21 May 08:21	Share

Actinogen CMO presents positive depression data at APA 2025
19 May 11:04	Share

ACW Science Forum today - Preparing for commercialization
15 May 09:21	Share

Actinogen March 2025 quarterly activity report & Appendix 4C
30 Apr 09:05	Share

ACW Science Forum notice - Preparing for commercialization
24 Apr 08:28	Share

Change in substantial holding
23 Apr 11:18	Share

ACW CMO presents Xanamem pTau poster at ADPD25 conference
02 Apr 12:28	Share

ACW conducts Type C meeting with FDA regarding depression
27 Mar 11:58	Share

Actinogen presentation to ASX small & mid-caps conference
26 Mar 11:06	Share

Appendix 3Ys x 5
24 Mar 16:58	Share

Notification of cessation of securities - ACW
24 Mar 16:44	Share

Notification of cessation of securities - ACW
24 Mar 16:44	Share

Application for quotation of securities - ACW
24 Mar 16:42	Share

Results of Meeting
14 Mar 10:35	Share

Notification of buy-back - ACW
04 Mar 16:56	Share

ACW HY25 results Advancing to latestage clinical development
24 Feb 15:28	Share

Actinogen HY2025 financial report and Appendix 4D
24 Feb 15:27	Share

Letter to Shareholders, Notice of GM & Proxy Form
10 Feb 13:28	Share

Peer-reviewed clinpharm manuscript published
06 Feb 13:34	Share

Application for quotation of securities - ACW
30 Jan 14:04	Share

ACW December 2024 quarterly activity report & Appendix 4C
29 Jan 08:58	Share

ACW presents at Sachs Neuro & WHO grants INN emestedastat
13 Jan 09:14	Share

Change in substantial holding
19 Dec 08:16	Share

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 2.5¢		Change 0.002(8.70%)		Mkt cap ! $76.25M

Open	High	Low	Value	Volume
2.4¢	2.5¢	2.4¢	$6.277K	257.3K

Buyers (Bids)

No.	Vol.	Price($)
4	876318	2.4¢

Sellers (Offers)

Price($)	Vol.	No.
2.5¢	1421427	5

View Market Depth

No.	Vol.	Price($)
4	876318	0.024
8	3130942	0.023
14	1973323	0.022
11	4074093	0.021
13	4237500	0.020

Price($)	Vol.	No.
0.025	1421427	5
0.026	915137	8
0.027	1791815	7
0.028	622900	5
0.029	1233142	3

Last trade - 16.10pm 11/08/2025 (20 minute delay)


Last 2.5¢			Change 0.002 ( 4.17 %)
Open	High		Low	Volume
2.4¢	2.5¢		2.4¢	577143
Last updated 15.18pm 11/08/2025 ?

ACW (ASX) Chart

SPONSORED BY